Method and Apparatus for OCT-Based Viscometry
US-2018242847-A1 · Aug 30, 2018 · US
US12419974B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12419974-B2 |
| Application number | US-202117365134-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 1, 2021 |
| Priority date | May 6, 2020 |
| Publication date | Sep 23, 2025 |
| Grant date | Sep 23, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure describes an imaging composition including porous silicon microparticles, and more particularly, to a biological tissue imaging composition including a composite in which oxidized porous silicon microparticles and silver nanoparticles are combined. Since a biological tissue imaging agent of the present invention, which includes a composite of oxidized porous silicon microparticles and silver nanoparticles, continuously provides an image signal without spreading in the body as compared to conventional imaging agents, it is possible to increase surgical stability by accurately identifying target tissues in vivo in an affected area.
Opening claim text (preview).
What is claimed is: 1. A composition for imaging of biological tissue by computed tomography (CT), comprising a composite in which oxidized porous silicon microparticles and silver nanoparticles are combined, wherein the silver nanoparticles are bonded into pores of the oxidized porous silicon microparticles and attached to a surface of the oxidized porous silicon microparticles, wherein the composite is dissolved in a mixture of glycerol and water in a ratio of 3:1, wherein the composition has in vivo local area reactivity, wherein a size of the porous silicon microparticles is in a range of 1 μm to 10 μm, and wherein the composite includes elemental silicon, elemental oxygen, and elemental silver in a weight ratio of 100:100 to 120:15 to 30. 2. The composition of claim 1 , wherein the biological tissue is lung tissue. 3. A method of manufacturing a composition for imaging of biological tissue by computed tomography (CT) according to claim 1 , comprising steps of: a) oxidizing porous silicon microparticles; b) attaching silver nanoparticles to the oxidized silicon microparticles to create a composite; and c) dissolving the composite in a mixture of glycerol and water in a ratio of 3:1, wherein a size of the porous silicon microparticles is in a range of 1 μm to 10 μm, and wherein the composite includes elemental silicon, elemental oxygen, and elemental silver in a weight ratio of 100:100 to 120:15 to 30. 4. The method of claim 3 , wherein the porous silicon microparticles oxidized in the step a) include an oxidized silicon (Si) framework (SiO 2 ). 5. The method of claim 3 , wherein, in the step b), the attaching of the silver nanoparticles is achieved using an aqueous silver bis-amine solution ([Ag(NH 3 ) 2 ) + ]). 6. The method of claim 3 , wherein the oxidizing is achieved using a borate.
Transmission computed tomography [CT] · CPC title
Manufacture or treatment of nanostructures · CPC title
Nanotechnology for materials or surface science, e.g. nanocomposites · CPC title
Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title
obtained by SEM · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.